The project will sequence 100,000 genomes from around 70,000 people. Participants are NHS patients with a rare disease, plus their families, and patients with cancer.
http://www.genomicsengland.co.uk/the-100000-genomes-project/
http://www.genomicsengland.co.uk/the-100000-genomes-project/understanding-genomics/… Read more
List of companies developing next-generation AAV vectors.
Multiple sclerosis (MS) is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body.
… Read more
The immune system is the body’s natural defence system. It is a collection of organs, cells and special molecules that helps protect you from infections, cancer and other diseases. When a different (foreign) organism enters into the body, for example a bacteria, the immune system recognises it and then attacks it, preventing it from causing harm. This process is called an immune response. Since cancer cells are very different from normal cells in the body, the immune system attacks them when it is able to recognise them. However, cancer cells … Read more
A Fundamental Transformation in Treating Cancer—Combining Modern Technology and the Immune System – UC Global Health Day 2015… Read more
Studying the human genome – the complete set of human genes – is a way of studying fundamental details about ourselves. The three billion letters of the human genome are written using the four-letter alphabet of DNA. The DNA is divided among 23 pairs of chromosomes that are found in each of the trillions of cells in our bodies. In 2003, The Human Genome Project produced a complete representative sequence of the human genome. Of course, people are not identical, and DNA sequences do differ subtly between individuals. Currently, a … Read more
Duchenne muscular dystrophy (DMD) is a rapidly progressive form of muscular dystrophy that occurs primarily in boys. It is caused by an alteration (mutation) in a gene, called the DMD gene that can be inherited
http://www.oraquick.com/Taking-the-Test/How-To-Video… Read more
Acute Myeloid Leukemia is the deadliest form of leukemia that affects mostly people over 60 years of age. ATNM’s most advanced product candidate is indicated for relapsed/refractory AML in adults 55 years and older. Of those, 64% do not receive any treatment other than supportive. The Company believes that upon continued demonstration of the current safety profile of the drug candidate its target indication can be expanded to include all elderly patients with newly diagnosed AML.… Read more
Enjoy and share this animation, sponsored by the Glenn Foundation for Medical Research and designed by acclaimed data journalist David McCandless. The clip supports “Live Longer, Live Well,” a collaboration between AFAR, the British Society for Research on Ageing, and the Glenn Foundation for Medical Research.
http://www.thebuck.org/… Read more
